Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Spero Therapeutics (SPRO) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Spero Therapeutics (SPRO) over the last 9 years, with Q3 2025 value amounting to 0.7.

  • Spero Therapeutics' Asset Utilization Ratio fell 663.5% to 0.7 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.7, marking a year-over-year decrease of 663.5%. This contributed to the annual value of 0.33 for FY2024, which is 5152.06% down from last year.
  • Latest data reveals that Spero Therapeutics reported Asset Utilization Ratio of 0.7 as of Q3 2025, which was down 663.5% from 0.69 recorded in Q2 2025.
  • Spero Therapeutics' 5-year Asset Utilization Ratio high stood at 0.75 for Q3 2024, and its period low was 0.08 during Q1 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.2 (2022), whereas its average is 0.36.
  • Data for Spero Therapeutics' Asset Utilization Ratio shows a peak YoY increase of 29985.74% (in 2024) and a maximum YoY decrease of 4553.19% (in 2024) over the last 5 years.
  • Over the past 5 years, Spero Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.12 in 2021, then skyrocketed by 73.62% to 0.2 in 2022, then soared by 257.13% to 0.72 in 2023, then crashed by 45.53% to 0.39 in 2024, then soared by 78.57% to 0.7 in 2025.
  • Its Asset Utilization Ratio stands at 0.7 for Q3 2025, versus 0.69 for Q2 2025 and 0.47 for Q1 2025.